BRIEF published on 10/24/2024 at 07:35, 28 days 9 hours ago Investissement majeur de Rentschler Biopharma dans son siège social allemand Investissement Rentschler Biopharma Produits Biopharmaceutiques Agrandissement Des Installations Laupheim
BRIEF published on 10/24/2024 at 07:35, 28 days 9 hours ago Rentschler Biopharma's Major Investment in German Headquarters Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE published on 10/24/2024 at 07:30, 28 days 9 hours ago Rentschler Biopharma announces largest single investment at its headquarters in Germany Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF published on 09/03/2024 at 13:05, 2 months 18 days ago Rentschler Biopharma présente une nouvelle boîte à outils de fabrication de vecteurs lentiviraux Thérapie Génique Produits Biopharmaceutiques Thérapies Avancées Vecteurs Lentiviraux Services De Fabrication
BRIEF published on 09/03/2024 at 13:05, 2 months 18 days ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 2 months 18 days ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 4 months 10 days ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
BRIEF published on 07/11/2024 at 14:05, 4 months 10 days ago Rentschler Biopharma dévoile une nouvelle ligne de production dans le Massachusetts Rentschler Biopharma Produits Biopharmaceutiques Massachusetts Ligne De Production
PRESS RELEASE published on 07/11/2024 at 14:00, 4 months 10 days ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 5 months 24 days ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
Published on 11/21/2024 at 16:30, 17 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 46 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 47 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 47 minutes ago Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 15:41, 1 hour 5 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 25 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 9 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 49 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 20 hours 39 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 21 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
